TrialDrug design, development and therapy2016

Very rapid virologic response and early HCV response kinetics, as quick measures to compare efficacy and guide a personalized response-guided therapy.

Mostafa Yakoot et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.